跳至主要内容
临床试验/IRCT20221206056734N1
IRCT20221206056734N1招募中3 期

Effect of L-carnitine supplementation on clinical status, anthropometric indices, and serum levels of some oxidative stress and inflammation biomarkers in ischemic stroke patients.

Ahvaz University of Medical Sciences0 个研究点目标入组 82 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
82

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Diagnosing and confirming the occurrence of ischemic stroke through clinical and neurological examinations by a neurologist and brain imaging (CT-Scan or MRI)
  • Be over 18 years old.
  • Body mass index be more than 18.5.
  • Having an NIHSS score of greater than 10 and less than 22.
  • The onset of symptoms be less than 24 hours.
  • Having focal neurologic deficit
  • Insensitivity to L-carnitine supplement
  • No history of previous stroke, craniotomy, and other CNS diseases such as seizures, epilepsy, brain tumor, severe brain injury, multiple sclerosis, Alzheimer's, Parkinson's, etc.
  • Not taking antioxidant or anti-inflammatory supplements or multivitamins in the last three months
  • Not suffering from chronic or acute liver and kidney disorders (kidney failure and dialysis)

排除标准

  • 未提供

研究者

相似试验